Robert A. Wolff

Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic index.

J. Vauthey, C. Charnsangavej, R. Wolff, 2001, Seminars in oncology.

Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix.

R. Wolff, M. Overman, K. Fournier, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer

J. Vauthey, M. Ballo, R. Wolff, 2001, International journal of gastrointestinal cancer.

Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma.

C. Charnsangavej, R. Wolff, P. Pisters, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Neoadjuvant therapy versus upfront surgical strategies in resectable pancreatic cancer: A Markov decision analysis.

R. Miksad, S. D. Geus, M. Eskander, 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

A Phase II trial of epothilone B analogue BMS-247550 (NSC #710428) ixabepilone, in patients with advanced pancreas cancer: A Southwest Oncology Group study

R. Wolff, S. Dakhil, J. Abbruzzese, 2006, Investigational New Drugs.

Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration

Jeffrey E. Lee, K. Hess, Douglas B. Evans, 2022 .

Abstracts reprinted from Journal of Clinical Oncology

C. Charnsangavej, P. Pisters, Karen R. Cleary, 2002, Annals of Surgical Oncology.